ResMed Inc. RMEA.F Stock
ResMed Inc. Price Chart
ResMed Inc. RMEA.F Financial and Trading Overview
ResMed Inc. stock price | 17.5 EUR |
Previous Close | 15.2 EUR |
Open | 14.9 EUR |
Bid | 15 EUR x 90000 |
Ask | 15.5 EUR x 90000 |
Day's Range | 14.9 - 14.9 EUR |
52 Week Range | 14.9 - 23.2 EUR |
Volume | 300 EUR |
Avg. Volume | 14 EUR |
Market Cap | 21.99B EUR |
Beta (5Y Monthly) | 0.478697 |
PE Ratio (TTM) | 26.14035 |
EPS (TTM) | 0.56 EUR |
Forward Dividend & Yield | 0.18 (1.15%) |
Ex-Dividend Date | August 16, 2023 |
1y Target Est | N/A |
RMEA.F Valuation Measures
Enterprise Value | 10.28B EUR |
Trailing P/E | 26.14035 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 5.207705 |
Price/Book (mrq) | 2.122356 |
Enterprise Value/Revenue | 2.435 |
Enterprise Value/EBITDA | 7.957 |
Trading Information
ResMed Inc. Stock Price History
Beta (5Y Monthly) | 0.478697 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 23.2 EUR |
52 Week Low | 14.9 EUR |
50-Day Moving Average | 18.81 EUR |
200-Day Moving Average | 19.95 EUR |
RMEA.F Share Statistics
Avg. Volume (3 month) | 14 EUR |
Avg. Daily Volume (10-Days) | 30 EUR |
Shares Outstanding | 1.47B |
Float | 582.76M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 7.51% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 1.76 |
Trailing Annual Dividend Yield | 11.57% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0.289 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2023 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | June 30, 2024 |
Profitability
Profit Margin | 21.25% |
Operating Margin (ttm) | 27.27% |
Gross Margin | 56.50% |
EBITDA Margin | 30.59% |
Management Effectiveness
Return on Assets (ttm) | 12.15% |
Return on Equity (ttm) | 23.96% |
Income Statement
Revenue (ttm) | 4.22B EUR |
Revenue Per Share (ttm) | 7.19 EUR |
Quarterly Revenue Growth (yoy) | 22.69% |
Gross Profit (ttm) | 2.39B EUR |
EBITDA | 1.29B EUR |
Net Income Avi to Common (ttm) | 897.56M EUR |
Diluted EPS (ttm) | 0.57 |
Quarterly Earnings Growth (yoy) | 17.69% |
Balance Sheet
Total Cash (mrq) | 240.31M EUR |
Total Cash Per Share (mrq) | 0.41 EUR |
Total Debt (mrq) | 1.58B EUR |
Total Debt/Equity (mrq) | 38.26 EUR |
Current Ratio (mrq) | 3.122 |
Book Value Per Share (mrq) | 7.0205 |
Cash Flow Statement
Operating Cash Flow (ttm) | 693.3M EUR |
Levered Free Cash Flow (ttm) | 415.36M EUR |
Profile of ResMed Inc.
Country | Germany |
State | CA |
City | San Diego |
Address | 9001 Spectrum Center Boulevard |
ZIP | 92123 |
Phone | 858-836-5000 |
Website | https://www.resmed.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 10140 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Q&A For ResMed Inc. Stock
What is a current RMEA.F stock price?
ResMed Inc. RMEA.F stock price today per share is 17.5 EUR.
How to purchase ResMed Inc. stock?
You can buy RMEA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ResMed Inc.?
The stock symbol or ticker of ResMed Inc. is RMEA.F.
Which industry does the ResMed Inc. company belong to?
The ResMed Inc. industry is Medical Instruments & Supplies.
How many shares does ResMed Inc. have in circulation?
The max supply of ResMed Inc. shares is 1.47B.
What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?
ResMed Inc. PE Ratio is 31.25000000 now.
What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?
ResMed Inc. EPS is 0.56 EUR over the trailing 12 months.
Which sector does the ResMed Inc. company belong to?
The ResMed Inc. sector is Healthcare.